Home > Press > Thermo Fisher Scientific Receives Patent Award for its Innovative New Raman Spectrometric Data Cleansing Method
Abstract:
Thermo Fisher Scientific Inc., the world leader in serving science, announces that it has been awarded a US Patent on Spectrometric Data Cleansing This patent describes a method for filtering artifacts from Raman spectra and is of particular use in removing the distorted data points generated by cosmic ray interference. Elimination of spectral artifacts facilitates automated analysis by such methods as reference library searches and correlation with standard spectra.
The patented method unlike more primitive correction schemes, introduces rigorous and objective criteria to the identification and removal of spurious data points. This ensures that spectrometric data cleansing is independent of the skill and judgment of the user and is therefore of immense value to laboratories where expert and non-expert users alike depend on Raman spectroscopy as a prime analytical tool. It is particularly important for those laboratories operating in regulated environments with a need to validate analytical methods.
Raman is now routinely used for compound identification, defect analysis and in QA/QC environments. It is now an invaluable tool in various industries including chemicals, petroleum, polymers, nanotechnology, alternate energy sources pharmaceuticals and forensics.
This method for Spectrometric Data Cleansing, patented under US Patent Number 7,233,870 B1, is incorporated into the Thermo Scientific OMNIC software suite and is standard with the Nicolet Almega XR dispersive Raman microscope.
For more information on Thermo Scientific Raman solutions, please call +1 800-532-4752, email or alternatively please visit www.thermo.com/raman to register for the online Thermo Fisher Molecular Spectroscopy eNewsletter, BASELINE™.
Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.
####
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike.
For more information, please click here
Contacts:
+1 800-532-4752
Copyright © Thermo Fisher Scientific Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Software
Visualizing nanoscale structures in real time: Open-source software enables researchers to see materials in 3D while they're still on the electron microscope August 19th, 2022
Luisier wins SNSF Advanced Grant to develop simulation tools for nanoscale devices July 8th, 2022
Oxford Instruments’ Atomfab® system is production-qualified at a market-leading GaN power electronics device manufacturer December 17th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||